Detalhe da pesquisa
1.
Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer.
Future Oncol
; 16(12): 749-762, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228198
2.
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC).
Cancer
; 124(24): 4667-4675, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383906
3.
Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice.
Future Oncol
; 14(23): 2415-2431, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29978725
4.
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.
Lancet
; 387(10030): 1837-46, 2016 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26970723
5.
Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.
Lancet Oncol
; 17(8): 1094-1104, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27345639
6.
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation.
Histopathology
; 69(2): 177-86, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27196116
7.
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
Lancet
; 384(9944): 665-73, 2014 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24933332
8.
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 13(11): 1161-70, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23078958
9.
Spatial heterogeneity of radiolabeled choline positron emission tomography in tumors of patients with non-small cell lung cancer: first-in-patient evaluation of [18F]fluoromethyl-(1,2-2H4)-choline.
Theranostics
; 10(19): 8677-8690, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32754271
10.
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
Eur J Cancer
; 120: 86-96, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499384
11.
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer.
JAMA Oncol
; 5(12): 1774-1778, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31513236
12.
Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer.
Lung Cancer
; 112: 126-133, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191585
13.
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
J Clin Oncol
; 35(4): 402-411, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893326
14.
Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial.
Eur J Cancer
; 83: 302-312, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28780466
15.
Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy.
Lung Cancer
; 93: 95-103, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26898621
16.
PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.
J Clin Oncol
; 34(9): 953-62, 2016 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26811519
17.
Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer.
Oncotarget
; 7(11): 13209-20, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26334099
18.
Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases.
J Natl Cancer Inst
; 106(7)2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25031274
19.
Superior vena cava stent migration into the pulmonary artery causing fatal pulmonary infarction.
Cardiovasc Intervent Radiol
; 34 Suppl 2: S198-201, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20135125
20.
A rare complication of finger sepsis secondary to blood glucose monitoring.
BMJ Case Rep
; 20092009.
Artigo
em Inglês
| MEDLINE | ID: mdl-22190989